Targeting cardiac hypertrophy: toward a causal heart failure therapy.

Targeting cardiac hypertrophy: toward a causal heart failure therapy.

Item
http://www.wikidata.org/entity/Q38257080
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of CardiologyMyocardial hypertrophy and its role in heart failure with preserved ejection fractionOngoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling.Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.Emergency Spatiotemporal Shift: The Response of Protein Kinase D to Stress Signals in the Cardiovascular System.Myozap Deficiency Promotes Adverse Cardiac Remodeling via Differential Regulation of Mitogen-activated Protein Kinase/Serum-response Factor and β-Catenin/GSK-3β Protein Signaling.Transcriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy.Noncoding RNAs in Heart Failure.Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling.Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats.SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes.Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.Growing a healthier heart.Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
P2860

Targeting cardiac hypertrophy: toward a causal heart failure therapy.

Item
http://www.wikidata.org/entity/Q38257080
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeting cardiac hypertrophy: toward a causal heart failure therapy.
@en
type
label
Targeting cardiac hypertrophy: toward a causal heart failure therapy.
@en
prefLabel
Targeting cardiac hypertrophy: toward a causal heart failure therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Targeting cardiac hypertrophy: toward a causal heart failure therapy.
@en
P2093
P304
P31
P356
10.1097/FJC.0000000000000126
P433
P478
P50
P577
P698
P921